Who owns QG5?
QG5 is made and sold by Genomma Lab (Mexico, BMV: LAB) under licence, an arrangement in place since 2009; Genomma Lab does not own the name.[1] The name is owned by another company.
Evidence: Genomma Lab Internacional — Reporte Anual 2025 (Anexo N, BMV), Genomma Lab Internacional, S.A.B. de C.V. Last checked .
Key facts
- Licensed to
- Genomma Lab Internacional, S.A.B. de C.V. reported
- Since
- Headquarters
- 🇲🇽 Mexico, Mexico City
- Origin
- 🇲🇽 Mexico
- Category
- Consumer health › Over-the-counter medicine › Digestive health
- Parent ticker
- BMV: LAB
- Last verified
- · 1 sources
About QG5
QG5 is an over-the-counter treatment for colitis that Genomma Lab has sold since 2009, when it bought the licensee rights to the name rather than the name itself, in the same transaction that gave it cosmetic rights to Sanborns. It is one of the more widely distributed products in the portfolio, listed for sale in Argentina, Brazil, Central America and the Caribbean, Chile, Peru and Bolivia as well as Mexico.
Ownership timeline of QG5
Where QG5 sits in Genomma Lab
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Genomma Lab ownership tree →
See the full Genomma Lab brand portfolio (13) →
Other brands owned by Genomma Lab
Genomma Lab controls 14 brands on Brandtree, 7 of them in consumer health.
Also in consumer health
Other brands in digestive health, and who owns them
The 25 brands in digestive health on Brandtree belong to 18 owners. The largest is Bayer, with 2; Genomma Lab has 2.
| Brand | Owner | Owner based in |
|---|---|---|
| Alka-Seltzer | Bayer | 🇩🇪 Germany |
| Daiichi Sankyo Stomach Medicine | Daiichi Sankyo Healthcare | 🇯🇵 Japan |
| Epocler | Hypera | 🇧🇷 Brazil |
| Entrostop | Kalbe Farma | 🇮🇩 Indonesia |
| Metamucil | Procter & Gamble | 🇺🇸 United States |
| Buscolysin | Sopharma | 🇧🇬 Bulgaria |
| Oracal | Birzeit Pharmaceutical | 🇵🇸 Palestine |
| First Response | Church & Dwight | 🇺🇸 United States |
About the owner: Genomma Lab
Genomma Lab is a publicly listed company headquartered in Mexico City, Mexico, founded in 1996.
Genomma Lab Internacional is a Mexican over-the-counter medicine and personal care company that began in 1996 as a direct-response advertiser making its own television infomercials, moved into developing products of its own from 1997, and floated on the Mexican stock exchange as LAB on 18 June 2008. It sells more than 50 active brands in Mexico and eighteen countries beyond it, and puts its share of the Mexican over-the-counter market at 5.9 per cent and of the personal care categories it competes in at 5.0 per cent. Much of the portfolio was bought rather than invented.
🇲🇽 QG5 and other Mexican brands
Brandtree records a controlling owner for 113 brands that began in Mexico. 28 of them (25%) are now controlled by a company headquartered in another country; QG5 is not one of them.
Frequently asked questions
Who makes QG5?
Genomma Lab makes and sells QG5 under a licensing agreement that has been in place since 2009.
Does Genomma Lab own QG5?
No. Genomma Lab holds a licence to make and sell QG5, which is not the same as owning it.
Where did QG5 come from?
QG5 originated in Mexico.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Genomma Lab Internacional — Reporte Anual 2025 (Anexo N, BMV) — Genomma Lab Internacional, S.A.B. de C.V., Annual report; retrieved 23 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.